Holen Sie sich die Stockscreener-App
1.92
1.54%
-0.03
Vorhandelsmarkt:
2.56
0.64
+33.33%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CAMP?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.95
Offen:
$1.9991
24-Stunden-Volumen:
32,165
Relative Volume:
0.92
Marktkapitalisierung:
$37.20M
Einnahmen:
$264.74M
Nettoeinkommen (Verlust:
$-49.71M
KGV:
-0.4688
EPS:
-4.0959
Netto-Cashflow:
$-43.55M
1W Leistung:
+4.07%
1M Leistung:
-36.63%
6M Leistung:
-79.40%
1J Leistung:
-47.83%
1-Tages-Spanne:
$1.8707
$2.00
1-Wochen-Bereich:
$1.67
$2.00
52-Wochen-Spanne:
$0.3901
$12.30
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
Firmenname
Camp 4 Therapeutics Corp
Sektor
Branche
Telefon
617-651-8867
Adresse
ONE KENDALL SQUARE, CAMBRIDGE, CA
Vergleichen Sie CAMP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAMP
Camp 4 Therapeutics Corp
|
1.92 | 37.20M | 264.74M | -49.71M | -43.55M | -4.0959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | Piper Sandler | Overweight |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
| 2022-08-16 | Hochstufung | Craig Hallum | Hold → Buy |
| 2021-12-22 | Herabstufung | Craig Hallum | Buy → Hold |
| 2021-09-24 | Bestätigt | Craig Hallum | Buy |
| 2021-06-25 | Bestätigt | Craig Hallum | Buy |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-04-17 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-05 | Bestätigt | Craig Hallum | Buy |
| 2019-12-20 | Bestätigt | Craig Hallum | Buy |
| 2019-12-20 | Herabstufung | First Analysis Sec | Outperform → Neutral |
| 2019-06-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2019-05-29 | Herabstufung | Goldman | Neutral → Sell |
| 2019-05-01 | Bestätigt | Craig Hallum | Buy |
| 2019-03-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-01-25 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-12-21 | Hochstufung | Craig Hallum | Hold → Buy |
| 2018-12-14 | Bestätigt | B. Riley FBR | Buy |
| 2018-12-11 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2018-12-11 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2018-11-27 | Eingeleitet | Goldman | Neutral |
| 2018-10-15 | Eingeleitet | Jefferies | Hold |
| 2018-09-28 | Bestätigt | Craig Hallum | Hold |
| 2018-04-27 | Bestätigt | Craig Hallum | Hold |
| 2018-03-08 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-02-16 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
Alle ansehen
Camp 4 Therapeutics Corp Aktie (CAMP) Neueste Nachrichten
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Daily Times Chronicle EventsBoy Scout Troop 42 Pancake Breakfast - Homenewshere.com
CAMP4 Therapeutics to Present Preclinical and Phase 1 Clinical Trial Data at 28th Annual Meeting of the American Society of Gene and Cell Therapy - Nasdaq
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting - The Manila Times
Revolutionary RNA Therapy Shows Promise: CAMP4 Unveils First Human Trial Data at Gene Therapy Conference - Stock Titan
Global School of Chess Announces 100 Full-Scholarship Seats for New Inclusivity & Awareness Camp - Yahoo Finance
Home | Department of Parks and Recreation - City and County of Honolulu (.gov)
Programmable Therapeutics Restore Gene Expression - Mirage News
10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer - The Globe and Mail
Explorer Finds Major Gold Structure in Ontario Camp - streetwisereports.com
Top 3 Health Care Stocks Poised for Big Gains in Q2 - NewsBreak: Local News & Alerts
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
CalAmp : Quadro Vehicles S.A. Taps LoJack Italia for Advanced Connected Vehicle Technology and Security - MarketScreener
Manasa Pamboor holds free camp for physiotherapy, speech therapy and counseling - Daijiworld
Free Camp for Physiotherapy, Speech Therapy, and Counselling at Manasa Pamboor - Mangalorean.com
CAMP4 Therapeutics Advances RNA-Based Therapeutics - TipRanks
Promising Developments and Solid Financials Support Buy Rating for CAMP4 Therapeutics - TipRanks
Piper Sandler Keeps Their Buy Rating on CAMP4 Therapeutics Corporation (CAMP) - The Globe and Mail
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update - Yahoo
Gunnison Copper Provides a Construction Update for the Johnson Camp Mine in Southeast Arizona - Yahoo Finance
CAMP4 Appoint Doug E. Williams, Ph.D., and Murray Stewart, DM FRCP To Board - citybiz
Camp4 Therapeutics expands board with two new directors By Investing.com - Investing.com Australia
Camp4 Therapeutics expands board with two new directors - Investing.com
CAMP4 Therapeutics Expands Board with New Director Appointments - TipRanks
Major Leadership Boost: CAMP4 Adds Drug Development Pioneers to Board - StockTitan
Stocks Turn Mixed as Magnificent Seven Stocks Fall - TradingView
Stocks Supported by Strength in Chip Stocks and Lower Bond Yields - TradingView
SMALL CAP IDEA: 'Flu Camp' rapid drug trial firm slashes big pharma costs - This is Money
Orchid Isle Dance Announces Connection Camp in Hawaii: Adventure Travel for the Social Dancer - Yahoo Finance
In Other News This Week: Vento launches €75M Fund II, Curve raises €44M, Perfuze secures €22M and more - Silicon Canals
Stocks Rebound as US Government Shutdown Seems Averted - TradingView
It Might Not Be A Great Idea To Buy Camping World Holdings, Inc. (NYSE:CWH) For Its Next Dividend - Yahoo Finance
KY House passes bill to protect conversion therapy, reverse Beshear’s executive order - Lexington Herald Leader
CAMP4 Therapeutics Corporation (CAMP): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey
12 Penny Stocks with Insider Buying in 2025 - Insider Monkey
(PDF) Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways - ResearchGate
RFK's plan to make America healthy again? Send people with mental health conditions to farms - Yahoo
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Fox Chase Cancer Center to Hold Fifth Annual Cancer Epigenetics Symposium - Fox Chase Cancer Center
Affordable and Free Summer Camps in Chicago - Mommy Poppins
CAMP4 to Participate in Upcoming Investor Conferences - The Manila Times
3 Key Healthcare Conferences Where CAMP4 Therapeutics Will Share Its regRNA Innovation - StockTitan
Trump to prepare facility at Guantanamo for 30,000 migrants - Reuters
Modest Final Quarter Completes Shaky Biotech IPO Comeback For 2024 - News & Insights
Camp Pendleton, Miramar prep for high winds through their unique terrains - fox5sandiego.com
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
CAMP4 Therapeutics CEO to Present Corporate Update at J.P. Morgan Healthcare Conference - StockTitan
Here are 71 Mass. life science firms presenting at J.P. Morgan - The Business Journals
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones - The Manila Times
Strategic Investment Boosts Exploration Plans in Ontario's Gold Camp - Streetwise Reports
Camp4 Therapeutics sees MAD safety and key biomarker data in 2H25 - TipRanks
Finanzdaten der Camp 4 Therapeutics Corp-Aktie (CAMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
3.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):